Lablabo creates pack for HRT treatment
Uses an airless metering dispenser with EasyFoil aluminium pouch
Lablabo’s pack consists of a Sillage airless metering dispenser with an EasyFoil aluminium pouch.
Made of an aluminium and polyethylen multilayer foil, this new pouch is said to ensure maximum protection of the product inside against oxygen and UV rays. Its cylindrical shape guarantees high restitution rates (up to 98% of the product delivered) and easy filling with basic equipment, the firm says.
The metering pump delivers a constant and precise dose of 0.92ml.
The Elestrin sales pack used by the Irish pharmaceutical firm includes two 38ml Sillage airless metering dispensers for a two-month treatment.
Lablabo, based in Annemasse, says it has Drug Master Files (DMFs) registered with the FDA for all of it products and received ISO 15378 certification last December.
You may also like
Pharmaceutical
![CellCarta adds Tempus to companion diagnostic commercialisation network]()
CellCarta adds Tempus to companion diagnostic commercialisation network
Read moreCellCarta has partnered with Tempus to expand its CDx Commercialization Lab Network, giving biopharma sponsors a route from companion diagnostic development and regulatory approval to commercial testing in US oncology practice
Trending Articles
You may also like
Pharmaceutical
![CellCarta adds Tempus to companion diagnostic commercialisation network]()
CellCarta adds Tempus to companion diagnostic commercialisation network
CellCarta has partnered with Tempus to expand its CDx Commercialization Lab Network, giving biopharma sponsors a route from companion diagnostic development and regulatory approval to commercial testing in US oncology practice
Drug Delivery
![SCHOTT Pharma expands portfolio for sensitive biologics with cartriQ BioPure]()
SCHOTT Pharma expands portfolio for sensitive biologics with cartriQ BioPure
The new high‑performance sterile glass cartridge is engineered for stability of complex biologics across their shelf life. It complements EVERIC pure vials and syriQ BioPure syringes, enabling an unbiased container choice across the drug lifecycle. Commercial launch is planned for year‑end at CPHI Milan 2026; samples are already available
Manufacturing
![SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs]()
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs
Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
